Avadel Pharmaceuticals PLC Sponsored ADR
(NASDAQ : AVDL)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ISRGIntuitive Surgical, Inc.
0.95%518.542.4%$511.08m
ABTAbbott Laboratories
1.82%72.020.8%$498.31m
MDTMedtronic PLC
0.97%93.670.6%$496.77m
TMOThermo Fisher Scientific Inc.
1.46%241.151.0%$460.82m
ALGNAlign Technology, Inc.
1.19%225.416.3%$441.52m
BAXBaxter International Inc.
1.02%66.501.7%$335.33m
BDXBecton, Dickinson and Company
2.55%246.161.1%$324.28m
EWEdwards Lifesciences Corporation
1.71%155.741.2%$293.97m
BSXBoston Scientific Corporation
2.06%37.221.1%$283.26m
ABMDABIOMED, Inc.
-0.31%319.783.3%$256.26m
SYKStryker Corporation
2.02%172.121.3%$250.54m
DXCMDexCom, Inc.
1.77%138.158.5%$194.19m
ZBHZimmer Biomet Holdings, Inc.
2.17%117.101.7%$147.63m
WATWaters Corporation
0.76%199.583.5%$142.74m
XRAYDENTSPLY International Inc.
0.60%37.203.1%$132.86m

Company Profile

Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its offers Bloxiverz, Vazculep, and Akovaz. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.